Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.25
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM
5.70
+0.45 (8.57%)
After-hours: Apr 17, 2025, 6:40 PM EST
Serina Therapeutics Employees
As of December 31, 2024, Serina Therapeutics had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees increased by 2 or 18.18% compared to the previous year.
Employees
13
Change (1Y)
2
Growth (1Y)
18.18%
Revenue / Employee
$4,308
Profits / Employee
-$857,000
Market Cap
52.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 2 | 18.18% |
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
SER News
- 4 days ago - Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit - GlobeNewsWire
- 10 days ago - Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease - GlobeNewsWire
- 12 days ago - Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 25 days ago - Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 26 days ago - Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewsWire
- 2 months ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire
- 2 months ago - Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 3 months ago - Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewsWire